• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Demant

297.40 DKK+1.85 %14/8 16:59
Less than 1K followers

DEMANT

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.85 %
+8.86 %
+26.12 %
+68.79 %
+38.20 %
+22.39 %
+10.80 %
-15.56 %
+911.56 %

Demant operates in the medical technology sector. The company specializes in the development of hearing aids and hearing loops. The company operates on a global level where the products are sold under various brands. The products are available through the company's distributors and sales channels. In addition to its main business, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and has its headquarters in Smörum.

Read more
Market cap
62.98B DKK
Turnover
89.31M DKK
Revenue
22.97B
EBIT %
16.68 %
P/E
40.68
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
All
Research
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-08-13 15:04

Demant A/S: Transactions with Demant shares by managers and closely associated parties

Demant
Analyst Comment2026-08-11 17:56

HCA Red Flag: Demant upgrades outlook more than analysts expected (AI)

The share is expected to open higher: Demant raised its 2026 operating profit midpoint to DKK 4,600M, exceeding analysts' expectations of DKK 4,539M. The catch: sales grew 18% before currency effects, yet the operating margin only reached 16.5% vs. 16.4% last year.

Demant
Press release2026-08-11 17:38

Demant A/S: Demant-owned Oticon announces launch of new flagship hearing aids

Demant

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-08-11 17:37

Demant A/S: Interim Report 2026

Demant
Regulatory press release2026-08-11 17:36

Demant A/S: Interim Report 2026 and upgraded financial outlook for 2026

Demant
Press release2026-05-06 12:30

Demant A/S: Expansion of Demant’s Executive Leadership Team

Demant
Regulatory press release2026-05-05 17:10

Demant A/S: Interim Management Statement for Q1 2026

Demant
Regulatory press release2026-04-08 11:04

Demant A/S: Completion of capital reduction

Demant
Regulatory press release2026-04-07 11:26

Demant A/S: Transactions with Demant shares by managers and closely related parties

Demant
Press release2026-03-31 11:41

Demant A/S: Investor news - Demant completes divestment of Oticon Medical

Demant
Regulatory press release2026-03-05 16:30

Demant A/S: Decisions of annual general meeting

Demant
Regulatory press release2026-02-03 07:57

Demant A/S: Notice to annual general meeting

Demant
Regulatory press release2026-02-03 07:34

Demant A/S: Changes to Demant's Board of Directors

Demant
Regulatory press release2026-02-03 07:32

Demant A/S: Annual Report 2025

Demant
Regulatory press release2026-02-03 07:31

Demant A/S: Annual Report 2025 and review of H2 2025

Demant
Press release2026-01-30 13:04

Demant A/S: Investor news - Demant completes divestment of EPOS

Demant
Regulatory press release2026-01-13 13:14

Demant A/S: Transactions with Demant shares by managers and closely related parties

Demant
Regulatory press release2025-12-20 01:29

Demant A/S: Demant sells EPOS to ACCO Brands

Demant
Regulatory press release2025-12-03 10:07

Demant A/S: Financial calendar 2026

Demant
Regulatory press release2025-12-01 11:56

Demant A/S: Demant closes the acquisition of KIND

Demant